SOUTH AFRICAN HEALTH PRODUCTS REGULATORY AUTHORITY (SAHPRA)

CALL FOR NOMINATIONS FOR MEMBERS TO SERVE ON THE CEO TECHNICAL ADVISORY SUB-COMMITTEE OF BIOLOGICALS FOR CELL AND GENE THERAPY 

The South African Health Products Regulatory Authority (SAHPRA) hereby invite nominations for candidates to serve as CEO Technical Advisory Committee members. 

SAHPRA is a Schedule 3A Public Entity established in terms of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965) to oversee the regulation of medicines, medical devices, and in vitro diagnostics (IVDs) intended for human and animal use; the licensing of manufacturers, wholesalers and distributors of medicines, medical devices and IVDs; and the conduct of clinical trials. 

REQUIREMENTS

The Technical Advisory Committees (TACs) are established in terms of Section 3(9) of the Medicines Act, as amended to investigate, and report to the Authority on any matter within its scope in terms of the Act. The CEO TAC is a team of external technical experts with adequate experience to provide advice on various technical and regulatory matters. Nominations are required for the Biological Medicines Sub Committee on Cell and Gene Therapy (CGT). 

Relevant Qualifications: Appropriate degree in medicine/clinical pharmacy. Post-graduate qualification in any of the following areas: Clinical Pharmacology / Oncology / Immunology / Molecular Biology and Genetic Engineering. 

Registration with the statutory regulatory board/council relating to his/her profession where applicable is recommended. 

Applicant must be in good standing with the regulatory board/ council with which he/ she is registered where applicable.

Exclusions

No person shall be eligible for appointment as an Expert for the Technical advisory Committee, if: - 

·       he or she is conflicted in terms of SAHPRA Policy on Management of Conflict of Interest (GOV02). 

·       he or she is disqualified under the Relevant Act applicable to his or her profession from practising as such. 

·       he or she has been found guilty of improper or disgraceful conduct at an inquiry held under ambit of the relevant Act. 

·       he or she is a patient as defined in section 1 of the Mental Health Care Act, 2002 (Act No. 17 of 2002).  

·       he or she has been convicted of an offence in respect whereof he or she was sentenced to imprisonment without the option of a fine or in the case of fraud.

·       he or she does not meet the minimum requirements. 

TERM OF OFFICE 

The term of office for Committee members will end on 30 November 2028 with the possibility to be appointed for a further term(s). 

PROCEDURE

·       A comprehensive CV, qualification/s and a motivation expressing area of expertise must be submitted online at https://apply.sahpra.org.za:6006  

·       Only documents in pdf must be uploaded. 

·       Further communication will be limited to nominated candidates with appropriate skill sets. 

Closing date for nominations is Friday, 21 August 2026 at 16h30. No late nominations will be accepted. 

Enquiries: Office of the CEO at CEOOffice@sahpra.org.za